Author: Emma Yasinski

Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

The Mpox (formerly known as monkeypox) outbreak in the US hit its peak in August of 2022, and has declined from causes about 400 illnesses a day to just one, but that doesn’t mean the danger is completely gone, the Centers for Disease Control and Prevention explained in a teleconference on May 18, 2023. In May 2023, the World Health Organization (WHO) declared an end to the global health emergency. While cases are fewer, breakouts are still happening. Between mid April 2023 and early May, experts identified an outbreak of 21 men with Mpox in the Chicago area. “All have…

Read More

Madeline Shonka told MedShadow it took her years to get an accurate lupus diagnosis. Even then, she had to go through trial and error with many different combinations of medications for treatment, all the while trying to decipher the best lifestyle changes to manage her condition. For example, she eventually discovered that making time for light exercise had a huge positive impact on her quality of life. Jill Dehlin, an RN who suffers from migraines, told MedShadow that tracking her symptoms helped immensely. “I recommend to everyone that I speak with to keep a journal or diary and keep track…

Read More